Clinical Trial Update: Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing sargramostim or hypertonic saline before sentinel lymph node biopsy in stage IB-II melanoma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stage Ib Melanoma
• Stage Iia Melanoma
• Stage Iib Melanoma
• Stage Iic Melanoma

Drugs mentioned

• Hypertonic Saline (Hypertonic saline)
• sargramostim (sargramostim)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Stage IB Melanoma, Stage IIA Melanoma | Phase 3 | Status: WITHDRAWN